Lucid Diagnostics Inc. , a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. announced that it has been named a GenomeWeb 2026 Best Places to Work honoree, marking its second consecutive year in the annual program recognizing top workplaces across the life sciences research, diagnostics and precision medicine sectors.
"Our team's shared passion and relentless dedication to preventing esophageal cancer are the foundation of our success," said Shaun O'Neil, President and Chief Operating Officer of Lucid Diagnostics. "This industry honor is particularly meaningful because it is based on direct feedback solicited from our team members and reflects our culture of collaboration, mutual respect, and commitment to excellence. With EsoGuard now fully reimbursed by Medicare nationwide, this culture will be a powerful asset as we expand our team to accelerate commercialization."